WASHINGTON (AP) — The Food and Drug Administration commissioner's effort to drastically shorten the review of drugs favored by President Donald Trump's administration is causing alarm across the ...
WASHINGTON (AP) — The Food and Drug Administration commissioner's effort to drastically shorten the review of drugs favored by President Donald Trump's administration is causing alarm across the ...
On April 15, President Donald Trump signed an Executive Order (EO) titled “Lowering Drug Prices by Once Again Putting Americans First,” outlining a renewed policy agenda to reduce prescription drug ...
As the Trump administration begins to make its mark on the Medicare drug price negotiation program, litigation over the program continues. In the two years since the first case challenging the program ...
Dr. Marty Makary, commissioner of the Food and Drug Administration, speaks at an event on addiction recovery in the Oval Office of the White House, Thursday, Jan. 29, 2026, in Washington, as Attorney ...
Ronald Schneider, B.S.Pharm., M.H.A.; Jonathan Bagby, R.N., M.B.A., M.S.N.; Russ Carlson, R.N., B.S.N., M.H.A. Am J Health Syst Pharm. 2008;65(23):2216-2219. In 1994 ...
BOSTON (SHNS) – Health officials are rolling out regulations to implement a 2024 law legalizing the use of certified medication aides in long-term care facilities, rules that supporters say will help ...
WASHINGTON — The Food and Drug Administration commissioner’s effort to drastically shorten the review of drugs favored by President Trump’s administration is causing alarm across the agency, stoking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results